Male Infertility Market Report 2026

Male Infertility Market Overview

• Male Infertility market size has reached to $4.33 billion in 2025 • Expected to grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: The Increasing Stress Levels Are Fueling The Growth Of The Market Due To Hormonal Disruption And Decreasing Sperm Quality • Market Trend: Strategic Partnerships Driving Innovation And Access In Male Infertility Treatment • North America was the largest region in 2025.

What Is Covered Under Male Infertility Market?

Male infertility is defined as a man's inability to cause pregnancy in a fertile female partner after one year of regular, unprotected sexual intercourse. It is typically due to problems with the quantity or quality of sperm and results from structural issues, hormonal imbalances, genetic conditions, or other health factors. The main treatment types for male infertility are medication, surgery, and assisted reproductive technology. Medication treatments for male infertility aim to correct hormonal imbalances or boost sperm production using drugs while avoiding synthetic testosterone due to its sperm-suppressing effects. It is diagnosed with various test types, such as sperm agglutination, deoxyribonucleic acid fragmentation technique, oxidative stress analysis, computer-assisted semen analysis, sperm penetration assay, and others, and is distributed through several distribution channels, including hospital pharmacies, pharmacies and drug stores, and online pharmacies, and is used by various end-users, such as hospitals and clinics, fertility centers, research institutes, and others.

What Is The Male Infertility Market Growth Forecast?

The male infertility market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising infertility rates due to environmental factors, increasing demand for ivf and icsi procedures, technological advancements in fertility diagnostics, growing male reproductive health awareness, expansion of fertility treatment access in emerging markets. Major trends in the forecast period include rising adoption of assisted reproductive technologies, increasing use of advanced sperm diagnostic tests, growing focus on hormonal and targeted drug therapies, expansion of microsurgical treatments for male infertility, increasing awareness and early diagnosis of male infertility.

Global Male Infertility Market Segmentation

1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology 2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types 3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies 4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users Subsegments: 1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists 2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures 3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm

What Is The Driver Of The Male Infertility Market?

The increasing stress levels are expected to propel the growth of the male infertility market going forward. Stress levels refer to the intensity of emotional, physical, or mental strain experienced in response to challenging situations or pressures. The rising stress levels stem from escalating work demands, where relentless pressure and high expectations cause burnout and disrupt mental health and work-life balance. Elevated stress levels can interfere with hormone balance, decrease sperm quality, and impair sexual function, leading to male infertility. Chronic stress disrupts cortisol and testosterone levels, contributing to a rise in infertility cases. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization of psychologists, 43% of adults in the US felt more anxious in 2024, compared to 37% in 2023 and 32% in 2022, indicating a consistent increase in anxiety levels. Therefore, the increasing stress levels are driving the growth of the male infertility industry.

Key Players In The Global Male Infertility Market

Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics

Global Male Infertility Market Trends and Insights

Major companies operating in the male infertility market are focusing on strategic partnership approaches to improve access to advanced fertility treatments across global markets. Strategic partnerships are collaborations between organizations that combine resources and expertise to achieve shared objectives. They help drive innovation, broaden market presence, and enhance R&D efforts. For instance, in June 2024, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, partnered with Posterity Health, a US-based male fertility clinic, to introduce a male fertility program on Ferring's Fertility Out Loud platform to educate men about their fertility. This initiative offers men a confidential online assessment and educational resources developed by reproductive urologists to help them understand their fertility status and reduce the stigma around male infertility, which contributes to up to 50% of infertility cases. The program aims to empower men to take early action, potentially improving the couple's path to parenthood by addressing male fertility issues sooner and more conveniently through digital tools and telehealth.

What Are Latest Mergers And Acquisitions In The Male Infertility Market?

In June 2024, CooperSurgical, a US-based fertility and women's healthcare company, acquired ZyMōt Fertility for an undisclosed amount. The acquisition aims to enhance CooperSurgical's ART portfolio by adding a patented sperm separation device that improves motile sperm selection and pregnancy outcomes. ZyMōt Fertility is a US-based company specializing in advanced sperm separation devices for male infertility.

Regional Insights

North America was the largest region in the male infertility market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Male Infertility Market?

The male infertility market consists of revenues earned by entities by providing services such as diagnostic testing, counseling and lifestyle guidance, and hormonal therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The male infertility market includes sales of fertility supplements, semen analysis kits, surgical devices, and lifestyle and sperm health devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Male Infertility Market Report 2026?

The male infertility market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the male infertility industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.